Promedius Inc.

Exciting News! 🚀 We are beyond thrilled to announce that four of our groundbreaking abstracts have been accepted at prestigious international societies! ✨ “Deep Learning Approach for Normal, Osteopenia and Osteoporosis Classification on Chest X-rays: A Multinational Investigation" has been accepted by the American Society for Bone and Mineral Research (ASBMR). This work highlights our innovative deep-learning model, which effectively classifies osteopenia and osteoporosis using widely accessible chest X-rays. This abstract also highlights the fact that it also included validation with the dataset from different ethnicities and regions. 🎉 We are also immensely proud to share that one of our esteemed researchers has been nominated for the Top Young Investigator Award at ASBMR 2024 for this very topic! In addition, we are proud to share that two more of our abstracts have been accepted by the ASBMR and one by the Radiological Society of North America (RSNA). These contributions represent significant strides in our mission to refine deep learning models for more precise osteoporosis diagnosis. Stay tuned for more updates as we continue this incredible journey! 🚶♀️

💌 Introducing the Promedius Inc. 2024 1H Workshop! 🌟 We are excited to share precious moments from our 2024 workshop. Under the theme "From Osteoporosis Solutions to Global Diffusion of Innovation", we had a fantastic opportunity to connect, learn, and inspire each other. Check out the video to relive our memories and join us on this exciting journey!

Promedius Inc. is now hiring! 📣 프로메디우스와 "Healthy Aging through AI"의 비전을 함께 실천해나갈 분들을 모십니다! [채용중인 직군] - Head of Business (사업총괄이사) - Medical Affairs - Market Access - Brand Manager - [Korea] Product & Clinical Marketing - Channel Marketing (Junior) 보다 자세한 채용 정보는 아래 프로메디우스 커리어 페이지를 참고해주세요 👇 https://lnkd.in/gmDrCA_X

Promedius Inc. is now hiring! 📣 프로메디우스와 "Healthy Aging through AI"의 비전을 함께 실천해나갈 분들을 모십니다! [채용중인 직군] - Head of Business (사업총괄이사) - Medical Affairs - Market Access - Brand Manager - [Korea] Product & Clinical Marketing - Channel Marketing (Junior) 보다 자세한 채용 정보는 아래 프로메디우스 커리어 페이지를 참고해주세요 👇 https://lnkd.in/gmDrCA_X

Promedius Inc. 의 국내/해외 사업을 총괄하실 'Head of Business'를 찾습니다. 프로메디우스의 성장단계를 감안하면, 이제 곧 제품의 사업성과 사업역량을 증명해야 하는 시기입니다. 따라서, 그동안 최소 인력으로 유지되어 온 비즈니스 부서를 본격적으로 세우고자 합니다. 의료기기 분야의 비즈니스 리더로서 성공적인 경험을 갖추신 분들의 적극적인 도전을 환영합니다! 💪 https://lnkd.in/gNRYAqDX

We are thrilled to officially announce DAVID SUNGHYUN JUNG as the new CEO (Chief Executive Officer) of Promedius Inc. 🎉 Ever since joining Promedius as Chief Business Officer in 2023, David has established remarkable milestones, including successfully completing a Series A2 funding round. Now, his role extends to CEO of Promedius where he will drive the company to new heights of success and growth. David emphasized his commitment towards Promedius' mission of "Healthy Aging through AI" by focusing on innovative AI solutions that encompass the entire cycle of osteoporosis screening, diagnosis, treatment, and management. Please join us in extending our warmest congratulations to him as he embarks on this exciting new journey. 💕 🌟 For further information, please refer to the news article below: bit.ly/3y297u6 #Promedius #AI #Leadership #Innovation #Osteoporosis #HealthyAging

Sarcopenia is defined as the gradual loss of muscle mass and strength, and it is closely related to osteoporosis and fractures, significantly impacting health-related quality of life (HRQoL). On World Sarcopenia Day, Promedius Inc. as a leading innovative AI company specialized in musculoskeletal diseases, stands alongside the International Osteoporosis Foundation and ESCEO, committed to supporting well-being and healthy life. 💪 International Osteoporosis Foundation has highlighted the 'Sarcopenia & Quality of Life (SarQoL) questionnaire' as a tool to address sarcopenia. The questionnaire is available in 30 languages (https://bit.ly/4eoix3m), and we strongly encourage you to take it to help safeguard your healthy aging. Promedius Inc. is here with you at every stage of your health management journey, striving to create a better future with our AI solutions for healthy aging. 🚶♂️🚶♀️

Promedius Inc. is pleased to announce the appointment of Professor Jean-Yves REGINSTER 🌿 to its Scientific Advisory Board (SAB), marking a significant step in our efforts to enhance global clinical research and commercialization strategies. Professor Jean-Yves Reginster is a co-founder and Secretary General of the International Osteoporosis Foundation, head of the World Health Organization Collaborating Center for Epidemiology of Musculoskeletal Health and Aging, and President of the ESCEO. His exceptional expertise and extensive experience are anticipated to significantly enhance the impact of our innovative osteoporosis screening technology "PROS CXR:OSTEO", and position Promedius as a global leading medical AI company, realizing our goal of "Healthy Aging through AI."

Promedius Inc. is pleased to announce that we have successfully wrapped up our debut at Bone Health & Osteoporosis Foundation ISO(Interdisciplinary Symposium on Osteoporosis) 2024. 🌟 As a proud member of CAR(Corporate Advisory Roundtable), we introduced our innovative AI technology, 'PROS® CXR: OSTEO'. We are revolutionizing osteoporosis management through this opportunistic screening solution and taking a significant step towards our goal of making a substantial global impact on bone health. We extend our heartfelt gratitude to the visitors and Bone Health & Osteoporosis Foundation ISO for their interest and support. 🙌 We look forward to a deeper engagement with the North American bone health societies to contribute to improving osteoporosis management in the region. 🔭